Read more at The Wall Street Journal.
Emerging Form of Targeted Cancer Therapy Draws Venture Capital
Date: |
Topics
Sort by
Filter
Date
Items per page
-
FDA approves Amgen's treatment for most deadly form of lung cancer
The FDA cleared the Amgen drug, called Imdelltra, as a treatment for patients with advanced small-cell lung cancer.CNBC - Business - FDA -
FDA Approves Amgen Drug for Persistently Deadly Form of Lung Cancer
The treatment is for patients with small cell lung cancer, which afflicts about 35,000 people in the U.S. a year.The New York Times - Science - FDA
More from The Wall Street Journal
-
China Consumption, Investment Slows Unexpectedly
Consumption and investment in China slowed unexpectedly in April, while industrial output beat expectations as Beijing doubled down on its manufacturing drive to spur growth.The Wall Street Journal - World - China -
Most Asian Currencies Weaken; China Economic Data in Focus
Most Asian currencies weakened against USD in the morning session in possible position adjustments following the greenback’s recent depreciation.The Wall Street Journal - World - China -
More »
Forget 9 to 5. These go-getters are working 5 to 9.The Wall Street Journal - World -
JGB Futures Fall; BOJ Bond Purchases in Focus
JGB futures fell in thin trading in the morning Tokyo session. Market participants were likely to focus on the BOJ’s bond purchase operations today.The Wall Street Journal - World -
Oil Edges Higher, Aided by Fed Rate-Cut Prospects
Oil edged higher in early trade, aided by prospects of Fed rate cuts which would help support the U.S. economy and energy demand.The Wall Street Journal - World - Federal Reserve